SHAWN HASSLER: Open Payments
NPI 1427122928 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,622 in 246 payments from 18 companies in 2025. Trend: 2023 $79,317 · 2024 $64,996 · 2025 $64,622
Speaker / faculty: $36,778Speaker / faculty: $8,031Food & beverage: $6,349Honoraria: $4,600Consulting: $4,560Travel & lodging: $4,304
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 71 | $34,833 |
| ViiV Healthcare Company | 56 | $10,538 |
| Napo Pharmaceuticals Inc | 7 | $8,254 |
| Theratechnologies Inc. | 17 | $5,139 |
| Merck Sharp & Dohme LLC | 15 | $3,775 |
| EMD Serono, Inc. | 23 | $643 |
| ABBVIE INC. | 11 | $254 |
| Novo Nordisk Inc | 12 | $252 |
| Antares Pharma, Inc. | 10 | $228 |
| Axsome Therapeutics, Inc. | 3 | $196 |
Products named: Biktarvy, Yeztugo, DOVATO, Mytesi, Descovy, EGRIFTA, PIFELTRO, CABENUVA.
Industry payments across CA — which companies pay providers there.
